BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4610225)

  • 1. [Fibrinolysis phenomenon (author's transl)].
    Fujimaki M; Suzuki H; Yasui T; Yatabe M; Ikematsu S
    Rinsho Byori; 1974 Aug; 22(Suppl):234-41. PubMed ID: 4610225
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of fibrin degradation products on different biological tests (author's transl)].
    Vila V; Aznar J; Regañon E
    Sangre (Barc); 1976; 21(4):814-26. PubMed ID: 1006498
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinolysis activities and factor XIII in the neonatal period. 1. Fibrinolysis activity and fibrin degradation products in the neonatal period].
    Yamada Z
    Nihon Shonika Gakkai Zasshi; 1971 Apr; 75(4):294-6. PubMed ID: 4252802
    [No Abstract]   [Full Text] [Related]  

  • 5. [Products of fibrinolytic cleavage and their clinical significance].
    Astedt B; Nilsson IM
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):84-94. PubMed ID: 4114588
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrin-fibrinogen degradation products in allergic disorders.
    Palma-Carlos AG; de Sá A; Joana-Geraldes M; Ducla-Soares J; Migueis-Clode MH
    Allergol Immunopathol (Madr); 1974; 2(6):419-22. PubMed ID: 4282697
    [No Abstract]   [Full Text] [Related]  

  • 7. The staphylococcal clumping test in the diagnosis of the intravascular coagulation. Preliminary note.
    Fumarola D; Marcuccio L; Semeraro N
    Ann Sclavo; 1971; 13(5):662-71. PubMed ID: 5005111
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro effect of Iopamidol on coagulation, fibrinolysis and complement system (author's transl)].
    Schulze B; Beyer HK
    Arzneimittelforschung; 1981; 31(7):1067-9. PubMed ID: 7196754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
    Konttinen YP; Kemppainen L; Turunen O
    Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estimation upon euglobulin clot lysis time, fibrin plate methods, and their clinical value (author's transl)].
    Fujita S
    Rinsho Byori; 1974 Aug; 22(8):539-44. PubMed ID: 4473623
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on coagulation and fibrinolysis. I. Fibrinolysodynamicogram and its application (author's transl)].
    Wang KQ; Shi QH; Lu ZQ; Cheng XK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Jun; 2(2):93-7. PubMed ID: 6448715
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ten years' advances in clinical pathology. (5) Clinical hematology-Blood coagulation and fibrinolysis (author's transl)].
    Umegaki K
    Rinsho Byori; 1976 May; 24(5):389-92. PubMed ID: 987329
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical haematology, coagulation and fibrinolysis (author's transl)].
    Umegaki K
    Rinsho Byori; 1976 Nov; Suppl 28():118-30. PubMed ID: 798049
    [No Abstract]   [Full Text] [Related]  

  • 14. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T; Jespersen J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK; Mitchell PS; Gorstein F
    Thromb Diath Haemorrh; 1967 May; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
    Conte J; Boneu B; Mignon-Conte ; Suc JM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical meanings of the coagulation and fibrolysis tests in liver diseases (author's transl)].
    Okabe K
    Rinsho Byori; 1980 Jan; 28(1):3-9. PubMed ID: 7373872
    [No Abstract]   [Full Text] [Related]  

  • 18. [An evaluation of euglobulin clot lysis time (ELT) measurement with the time saving recorder (author's transl)].
    Amemiya Y; Amaki I; Ariga T; Sawai H; Oshiba S
    Rinsho Ketsueki; 1973 Oct; 14(10):1008-17. PubMed ID: 4796985
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of coagulation by fibrinopeptides released during fibrinolysis.
    Schneider CL; Engstrom RM
    Bibl Anat; 1969; 10():469-73. PubMed ID: 5407402
    [No Abstract]   [Full Text] [Related]  

  • 20. Formation of anticoagulants by digesting fibrin with thrombin.
    Triantaphyllopoulos DC; Muirhead CR
    Thromb Diath Haemorrh; 1968 Jul; 19(3):397-402. PubMed ID: 5304346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.